DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Kissimmee, FL

16 verified pulmonary disease doctors in Kissimmee.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Florida Board of Medicine

Dr. Fortune Alabi, MD

Pulmonary Disease

21 yrs NPPES
NPI 1124025309
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $389,002 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$389,002

Total received

348

Transactions

40

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$143,953
GlaxoSmithKline, LLC.$105,557
AstraZeneca Pharmaceuticals LP$43,980
Roche Products Limited$20,080
E.R. Squibb & Sons, L.L.C.$19,756
Boehringer Ingelheim International GmbH$15,001

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Fortune Alabi do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jose Urdaneta-Jaimes, MD

Pulmonary Disease

20 yrs NPPES
NPI 1689645921
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Fred Umeh, MD

Pulmonary Disease

20 yrs NPPES
NPI 1114995842
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $75,439 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$75,439

Total received

182

Transactions

24

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$55,738
AstraZeneca Pharmaceuticals LP$13,399
Insmed, Inc.$4,003
Boehringer Ingelheim Pharmaceuticals, Inc.$375.04
Grifols USA, LLC$266.19
Actelion Pharmaceuticals US, Inc.$238.88

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Fred Umeh do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mario Pelletier, MD

Pulmonary Disease

20 yrs NPPES
NPI 1457310724
920 N JOHN YOUNG PKWY, Kissimmee, FL 34741(407) 956-1920
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $888.17 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$888.17

Total received

19

Transactions

4

Paying companies

Top paying companies

Amgen Inc.$444.24
AstraZeneca Pharmaceuticals LP$299.76
GlaxoSmithKline, LLC.$114.91
Novo Nordisk Inc$29.26

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 78th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mario Pelletier do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Rhoderick Nazario, MD

Pulmonary Disease

20 yrs NPPES
NPI 1962466730
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registry
CMS Open Payments· $1,599 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,599

Total received

67

Transactions

17

Paying companies

Top paying companies

Regeneron Healthcare Solutions, Inc.$225.27
GlaxoSmithKline, LLC.$218.27
Actelion Pharmaceuticals US, Inc.$191.47
AstraZeneca Pharmaceuticals LP$150.20
Takeda Pharmaceuticals U.S.A., Inc.$144.39
Pulmonx Corporation$144.27

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Rhoderick Nazario do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Thomas O'Brien, MD

Pulmonary Disease

20 yrs NPPES
NPI 1396700803
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registry
CMS Open Payments· $63,534 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$63,534

Total received

77

Transactions

19

Paying companies

Top paying companies

United Therapeutics Corporation$21,275
GlaxoSmithKline, LLC.$18,453
AstraZeneca Pharmaceuticals LP$15,018
Chiesi USA, Inc.$7,500
Jazz Pharmaceuticals Inc.$372.43
Regeneron Healthcare Solutions, Inc.$195.58

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Thomas O'Brien do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Remberto Bitar, MD

Pulmonary Disease

20 yrs NPPES
NPI 1386609899
1121 N CENTRAL AVE, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. James Lucio, MD

Pulmonary Disease

20 yrs NPPES
NPI 1649235151
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $904.25 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$904.25

Total received

41

Transactions

15

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$179.11
Regeneron Healthcare Solutions, Inc.$134.17
Takeda Pharmaceuticals U.S.A., Inc.$73.31
Mylan Specialty L.P.$68.47
GlaxoSmithKline, LLC.$65.83
NOVARTIS PHARMACEUTICALS CORPORATION$63.79

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to James Lucio do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Adam Griggs, DO

Pulmonary Disease

20 yrs NPPES
NPI 1043275647
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,113 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,113

Total received

93

Transactions

21

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$281.18
Regeneron Healthcare Solutions, Inc.$272.13
AstraZeneca Pharmaceuticals LP$234.21
Actelion Pharmaceuticals US, Inc.$181.29
Boehringer Ingelheim Pharmaceuticals, Inc.$174.50
Pulmonx Corporation$159.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Adam Griggs do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Donald Elton, MD

Pulmonary Disease

20 yrs NPPES
NPI 1538126685
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,496 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,496

Total received

30

Transactions

13

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$432.11
Actelion Pharmaceuticals US, Inc.$308.88
GlaxoSmithKline, LLC.$158.71
Grifols USA, LLC$152.05
La Jolla Pharmaceutical Company$128.60
IDORSIA PHARMACEUTICALS US INC$124.65

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Donald Elton do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Muhammad Shaukat, MD

Pulmonary Disease

20 yrs NPPES
NPI 1275553398
1115 N CENTRAL AVE, Kissimmee, FL 34741(407) 944-3500
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $45.13 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$45.13

Total received

1

Transactions

1

Paying companies

Top paying companies

Abbott Laboratories$45.13

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 53th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Muhammad Shaukat do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Joseph Ameh, MD

Pulmonary Disease

20 yrs NPPES
NPI 1225144579
1121 N CENTRAL AVE, SUITE B, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,423 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,423

Total received

42

Transactions

12

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$355.27
Regeneron Healthcare Solutions, Inc.$301.53
Actelion Pharmaceuticals US, Inc.$127.60
Pulmonx Corporation$127.19
Takeda Pharmaceuticals U.S.A., Inc.$110.37
Gilead Sciences, Inc.$107.87

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Joseph Ameh do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Maximo Lama, MD

Pulmonary Disease

17 yrs NPPES
NPI 1326276445
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $61,277 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$61,277

Total received

221

Transactions

26

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$57,138
AstraZeneca Pharmaceuticals LP$1,092
Actelion Pharmaceuticals US, Inc.$605.18
Grifols USA, LLC$384.70
Boehringer Ingelheim Pharmaceuticals, Inc.$324.42
Takeda Pharmaceuticals U.S.A., Inc.$305.11

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Maximo Lama do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Arelis Cordero-Gomez, MD

Pulmonary Disease

13 yrs NPPES
NPI 1437594942
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,840 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,840

Total received

101

Transactions

19

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$942.01
GlaxoSmithKline, LLC.$665.42
Grifols USA, LLC$196.25
La Jolla Pharmaceutical Company$128.60
IDORSIA PHARMACEUTICALS US INC$124.65
Regeneron Healthcare Solutions, Inc.$118.45

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Arelis Cordero-Gomez do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Miguel Ortiz-Bonilla, MD

Pulmonary Disease

12 yrs NPPES
NPI 1366869422
3480 POLYNESIAN ISLE BLVD, Kissimmee, FL 34746(407) 507-2615
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,162 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,162

Total received

53

Transactions

13

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$497.70
GlaxoSmithKline, LLC.$283.01
Regeneron Healthcare Solutions, Inc.$272.94
Actelion Pharmaceuticals US, Inc.$263.43
Boehringer Ingelheim Pharmaceuticals, Inc.$204.01
Grifols USA, LLC$152.05

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Miguel Ortiz-Bonilla do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Viral Patel, MD

Pulmonary Disease

11 yrs NPPES
NPI 1942691209
1121 N CENTRAL AVENUE, Kissimmee, FL 34741(407) 933-1221
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $645.79 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$645.79

Total received

26

Transactions

13

Paying companies

Top paying companies

Pulmonx Corporation$113.85
GlaxoSmithKline, LLC.$105.21
Boehringer Ingelheim Pharmaceuticals, Inc.$93.26
Inogen, Inc.$60.93
Organogenesis Inc.$55.38
Takeda Pharmaceuticals U.S.A., Inc.$54.13

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Viral Patel do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Kissimmee, FL — Verified | DoctorsProof | DoctorsProof